Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ZTS

Zoetis Inc

Nov 05 • 04:00PM ET

120.49

-3.97 -3.19 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NYSE

Peers: ELAN IDXX VTRS CTLT ANIK KRYS

| Held by: VTI VOO VUG IVV SPY XLV VIG VHT IWF QUAL

Scroll to Statements

Index	S&P 500	P/E	20.30	EPS (ttm)	5.93	Insider Own	0.18%	Shs Outstand	443.18M	Perf Week	-16.29%
Market Cap	53.10B	Forward P/E	17.59	EPS next Y	6.85	Insider Trans	-0.08%	Shs Float	442.39M	Perf Month	-15.61%
Enterprise Value	58.29B	PEG	2.49	EPS next Q	1.44	Inst Own	96.96%	Short Float	1.97%	Perf Quarter	-18.72%
Income	2.65B	P/S	5.65	EPS this Y	7.17%	Inst Trans	1.08%	Short Ratio	2.89	Perf Half Y	-22.76%
Sales	9.40B	P/B	9.85	EPS next Y	7.96%	ROA	17.96%	Short Interest	8.73M	Perf YTD	-26.05%
Book/sh	12.23	P/C	25.48	EPS next 5Y	8.16%	ROE	49.87%	52W High	181.85 -33.74%	Perf Year	-33.78%
Cash/sh	4.73	P/FCF	23.70	EPS past 3/5Y	8.55% 11.91%	ROIC	20.92%	52W Low	122.00 -1.24%	Perf 3Y	-20.09%
Dividend Est.	1.99 (1.66%)	EV/EBITDA	14.48	Sales past 3/5Y	5.98% 8.14%	Gross Margin	70.29%	Volatility	2.98% 1.99%	Perf 5Y	-25.25%
Dividend TTM	2.00 (1.66%)	EV/Sales	6.20	EPS Y/Y TTM	11.51%	Oper. Margin	37.63%	ATR (14)	4.08	Perf 10Y	178.01%
Dividend Ex-Date	Oct 31, 2025	Quick Ratio	2.28	Sales Y/Y TTM	2.68%	Profit Margin	28.21%	RSI (14)	16.32	Recom	1.57
Dividend Gr. 3/5Y	18.93% 21.14%	Current Ratio	3.64	EPS Q/Q	8.17%	SMA20	-15.29%	Beta	0.98	Target Price	181.86
Payout	32.86%	Debt/Eq	1.35	Sales Q/Q	0.50%	SMA50	-17.26%	Rel Volume	2.76	Prev Close	124.46
Employees	13800	LT Debt/Eq	1.35	Earnings	Nov 04 BMO	SMA200	-22.80%	Avg Volume	3.02M	Price	120.49
IPO	Feb 01, 2013	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.88% -0.41%	Trades		Volume	8,353,315	Change	-3.19%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-17-25	Downgrade	Leerink Partners	Outperform → Market Perform	$155
Jun-18-25	Downgrade	Stifel	Buy → Hold	$160
Dec-02-24	Initiated	Leerink Partners	Outperform	$215
Jul-25-24	Initiated	BTIG Research	Buy	$220
Jan-12-24	Reiterated	Stifel	Buy	$195 → $215
Dec-19-23	Resumed	Jefferies	Buy	$230
Dec-07-23	Initiated	Exane BNP Paribas	Outperform	$237
Sep-06-23	Initiated	HSBC Securities	Buy	$230
Jul-12-22	Initiated	Piper Sandler	Overweight	$205
Nov-18-21	Initiated	Morgan Stanley	Overweight	$40
Nov-18-21	Initiated	Morgan Stanley	Overweight	$264
Aug-05-21	Resumed	Credit Suisse	Outperform	$206
Jul-16-21	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-08-21	Upgrade	Raymond James	Mkt Perform → Outperform	$166
Mar-08-21	Upgrade	BofA Securities	Neutral → Buy	$180
Sep-21-20	Initiated	Atlantic Equities	Overweight	$191
Aug-14-20	Upgrade	Edward Jones	Hold → Buy
Aug-12-20	Downgrade	Gabelli & Co	Buy → Hold
May-27-20	Initiated	Jefferies	Buy	$152
Jan-10-20	Initiated	Raymond James	Mkt Perform

Show Previous Ratings

Nov-05-25 06:00PM	Diamond Hill Capital's Strategic Moves: A Closer Look at Zoetis Inc. (GuruFocus.com)
10:09AM	Zoetis (ZTS) Hits New 52-Week Low on Dismal Outlook (Insider Monkey)
12:31AM	ZTS Q3 Deep Dive: Flat Sales, Guidance Cut Amid Competitive and Market Pressures (StockStory)
Nov-04-25 04:07PM	Zoetis Inc (ZTS) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Competitive Pressures (GuruFocus.com) -13.78%
04:05PM	Why Zoetis (ZTS) Shares Are Plunging Today (StockStory)
01:51PM	Loading…
01:51PM	Analyst Report: Zoetis Inc. (Morningstar Research)
11:43AM	ZTS Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down (Zacks)
11:18AM	Stock Market Today: Stocks Continue Sinking As Rally Hopes Fade, Gov't Shutdown Ties 35 Day Record (TheStreet)
09:30AM	Compared to Estimates, Zoetis (ZTS) Q3 Earnings: A Look at Key Metrics (Zacks)
09:27AM	Zoetis Crumbles On Slashed 2025 Outlook As Growth Fears Mount (Investor's Business Daily)
08:59AM	This Animal Health Stock Tanks on Earnings. Pig and Chicken Medication Revenue Slumps. (Barrons.com)
08:29AM	Zoetis Stock Crumbles After Slashing 2025 Sales Outlook (Investor's Business Daily)
08:10AM	Zoetis (ZTS) Surpasses Q3 Earnings Estimates (Zacks)
07:42AM	Zoetis (NYSE:ZTS) Reports Q3 In Line With Expectations But Stock Drops (StockStory)
07:06AM	Zoetis: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Loading…
07:00AM	Zoetis Announces Third Quarter 2025 Results (Business Wire)
Nov-03-25 04:28PM	How Idexx Laboratories Business Shook Off Bears And Hit A Record (Investor's Business Daily)
04:15PM	Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026 (Business Wire)
Nov-02-25 10:05PM	What To Expect From Zoetis's (ZTS) Q3 Earnings (StockStory)
09:15AM	2 Magnificent Dividend Stocks to Buy and Hold Forever (Motley Fool)
07:40AM	Fed fallout, missing jobs numbers, and a busy earnings calendar: What to watch this week (Yahoo Finance)
Oct-30-25 09:15AM	Seeking Clues to Zoetis (ZTS) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics (Zacks)
08:32AM	Should You Consider Adding Zoetis (ZTS) to Your Portfolio? (Insider Monkey)
Oct-29-25 01:47PM	Zoetis Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
10:00AM	Earnings Preview: Catalyst Pharmaceutical (CPRX) Q3 Earnings Expected to Decline (Zacks)
Oct-28-25 10:00AM	Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:30AM	Zoetis Appoints Stephanie Tilenius to its Board of Directors (Business Wire)
Oct-27-25 06:15PM	Zoetis (ZTS) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
11:40AM	GRFS vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
Oct-22-25 05:55PM	Zoetis Inc. (ZTS): A Bull Case Theory (Insider Monkey)
08:50AM	Loading…
08:50AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks)
Oct-21-25 01:06PM	What to Expect From Zoetis' Q3 2025 Earnings Report (Barchart)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-16-25 09:06AM	Xeris Biopharma (XERS) Surges 14.2%: Is This an Indication of Further Gains? (Zacks)
Oct-15-25 07:00AM	Zoetis Announces Health Canada Approval of Lenivia (izenivetmab injection) for Alleviation of Osteoarthritis (OA) Pain in Dogs (Business Wire)
Oct-14-25 12:10PM	Why Zoetis (ZTS) is Poised to Beat Earnings Estimates Again (Zacks)
Oct-13-25 01:06PM	Zoetis Gains CVMP Backing for Lenivia, Eyes EU Approval in Dog OA Pain (Zacks)
10:36AM	Analyst Report: Zoetis Inc. (Morningstar Research)
Oct-10-25 04:15PM	Zoetis Receives Positive Opinion from CVMP for Lenivia (izenivetmab) to Reduce Pain Associated with Osteoarthritis (OA) in Dogs (Business Wire)
Oct-09-25 04:15PM	Zoetis Declares Fourth Quarter 2025 Dividend (Business Wire)
Oct-08-25 07:15AM	2 Magnificent Dividend Stocks to Buy Now and Hold Forever (Motley Fool)
02:00AM	Why Zoetis (ZTS) Remains a Reliable Choice for Investors Seeking Profitable Dividend Stocks (Insider Monkey)
Oct-05-25 04:20AM	My 2 Favorite Stocks to Buy Right Now (Motley Fool)
Oct-02-25 07:00PM	Zoetis: A Solid Investment in the Growing Pet Medicine Market? (Motley Fool)
Oct-01-25 01:54PM	Zoetis Inc. (ZTS) Could Launch First Long-Acting Anti-NGF Therapy for Cats in Q4 2025 (Insider Monkey)
Sep-30-25 04:15PM	Zoetis Receives Conditional Approval for Dectomax-CA1 Injectable for the Prevention and Treatment of New World Screwworm Myiasis in Cattle (Business Wire)
Sep-29-25 11:40AM	SDZNY or ZTS: Which Is the Better Value Stock Right Now? (Zacks)
Sep-26-25 06:15PM	Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
Sep-23-25 07:02PM	EMA Gives Positive Opinion on Zoetis Inc. (ZTS)' Cat Arthritis Therapy, Portela (Insider Monkey)
08:30AM	Zoetis to Host Webcast and Conference Call on Third Quarter 2025 Financial Results (Business Wire)
Sep-16-25 02:58PM	Zoetis (ZTS) Receives Positive Opinion from CVMP for Portela (Insider Monkey)
Sep-15-25 06:15PM	Zoetis (ZTS) Stock Declines While Market Improves: Some Information for Investors (Zacks)
09:52AM	Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain (Zacks)
Sep-12-25 12:09PM	Zoetis Receives Positive Opinion from CVMP for Portela (relfovetmab) to Alleviate Pain Associated with Osteoarthritis in Cats (Business Wire)
11:40AM	SDZNY vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
11:12AM	Zoetis Inc. (ZTS) Secures a New Five-Year $1.25 Billion Senior Unsecured Revolving Credit Facility (Insider Monkey)
Sep-09-25 06:15PM	Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why (Zacks)
09:34AM	Zoetis (ZTS) Fell in Line With Broader Health Care Sector (Insider Monkey)
01:01AM	ZTS- An Attractive Dividend Growth Play in the Animal Health Business (MoneyShow)
Sep-04-25 02:32PM	Is Zoetis Stock Underperforming the Nasdaq? (Barchart)
Sep-02-25 03:28AM	Zoetis Inc. (ZTS) Reports $2.5B Q2 Revenue, Raises Full-Year Outlook on Strong Pet Care Demand (Insider Monkey)
Aug-29-25 08:30AM	If You Invested $1000 in Zoetis a Decade Ago, This is How Much It'd Be Worth Now (Zacks)
Aug-27-25 11:40AM	SDZNY or ZTS: Which Is the Better Value Stock Right Now? (Zacks)
08:30AM	Zoetis to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (Business Wire)
Aug-25-25 12:03AM	2 Reasons to Watch ZTS and 1 to Stay Cautious (StockStory)
Aug-17-25 11:33PM	Winners And Losers Of Q2: Zoetis (NYSE:ZTS) Vs The Rest Of The Branded Pharmaceuticals Stocks (StockStory)
Aug-13-25 12:30AM	[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:19AM	ZTS Q2 Deep Dive: Market Questions Librela Outlook Amid Double-Digit Growth in Core Franchises (StockStory)
12:02AM	5 Revealing Analyst Questions From Zoetis's Q2 Earnings Call (StockStory)
Aug-12-25 10:30AM	Global Veterinary Regenerative Medicine Market Size/Share Worth USD 1395.44 Million by 2034 at a 13.23% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
05:52AM	Got $1,000? 3 Dividend Stocks to Buy and Hold Forever (Motley Fool)
Aug-11-25 06:48PM	Zoetis Announces Pricing of $1.85 Billion of Senior Notes (Business Wire)
01:56PM	If You'd Invested $1,000 in Zoetis (ZTS) Stock 10 Years Ago, Here's How Much You'd Have Today (Motley Fool)
11:40AM	SDZNY vs. ZTS: Which Stock Is the Better Value Option? (Zacks)
11:28AM	Are Wall Street Analysts Predicting Zoetis Stock Will Climb or Sink? (Barchart)
Aug-10-25 10:38AM	2 Stocks to Buy With $5,000 and Hold for a Decade (Motley Fool)
Aug-09-25 11:59PM	BofA Kept $200 Target on Zoetis (ZTS) as Competitive Threat Seen Modest (Insider Monkey)
Aug-06-25 09:45AM	Why Zoetis (ZTS) is a Top Growth Stock for the Long-Term (Zacks)
Aug-05-25 04:21PM	Zoetis Reverses And Dives As Its Arthritis Setback Continues (Investor's Business Daily)
03:36PM	Analyst Report: Zoetis Inc. (Morningstar Research)
03:00PM	Zoetis CFO talks Q2 beat & education's role in pet med adoption (Yahoo Finance Video)
01:56PM	Zoetis Inc. (ZTS): A Bull Case Theory (Insider Monkey)
12:21PM	ZTS Q2 Earnings & Revenues Beat Estimates, '25 Outlook Raised (Zacks)
10:50AM	Zoetis Lifts Outlook As Companion Animal Portfolio Offsets Librela Decline (Benzinga)
09:30AM	Zoetis (ZTS) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:06AM	Zoetis Surges After Crushing Expectations And Raising Its Outlook (Investor's Business Daily)
08:24AM	Animal healthcare firm Zoetis raises annual forecast on strong pet product demand (Reuters)
08:10AM	Zoetis (ZTS) Q2 Earnings and Revenues Surpass Estimates (Zacks)
07:59AM	Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars (StockStory)
07:30AM	1 Top Dividend Growth Stock to Buy and Hold Forever (Motley Fool)
07:07AM	Zoetis: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Zoetis Announces Second Quarter 2025 Results, Raises Full Year 2025 Outlook (Business Wire)
Aug-04-25 04:05PM	Acadia Pharmaceuticals Appoints Scott Cenci as Chief Information and Data Officer (Business Wire)
12:23PM	Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards? (Zacks)
08:15AM	BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
Aug-03-25 11:09PM	Zoetis (ZTS) Reports Earnings Tomorrow: What To Expect (StockStory)
Aug-02-25 07:48AM	Zoetis (ZTS) Stock Rated Overweight as Key Franchises Remain Strong Amid Competition (Insider Monkey)
Aug-01-25 11:23AM	Zoetis Gears Up to Report Q2 Earnings: Here's What to Expect (Zacks)
Jul-31-25 09:15AM	Countdown to Zoetis (ZTS) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Jul-30-25 06:15PM	Here's Why Zoetis (ZTS) Fell More Than Broader Market (Zacks)

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Lagano Roxanne	Executive Vice President	Jun 03 '25	Sale	170.00	652	110,840	15,129	Jun 04 04:31 PM
Lagano Roxanne	Officer	Jun 03 '25	Proposed Sale	170.00	652	110,840		Jun 03 04:22 PM
Reed Willie M	Director	Mar 11 '25	Proposed Sale	166.14	1,210	201,029		Mar 11 04:27 PM
Lagano Roxanne	Executive Vice President	Mar 10 '25	Sale	170.00	326	55,420	15,781	Mar 11 04:20 PM
Reed Willie M	Director	Mar 11 '25	Sale	166.14	1,210	201,029	11,245	Mar 11 04:20 PM
Lagano Roxanne	Officer	Mar 10 '25	Proposed Sale	170.00	326	55,420		Mar 10 05:17 PM
PECK KRISTIN C	Chief Executive Officer	Feb 19 '25	Option Exercise	46.09	382	17,606	94,576	Feb 20 04:07 PM
PECK KRISTIN C	Chief Executive Officer	Feb 19 '25	Sale	156.68	382	59,852	94,194	Feb 20 04:07 PM
PECK KRISTIN C	Officer	Feb 19 '25	Proposed Sale	156.68	382	59,852		Feb 19 05:18 PM
Lagano Roxanne	Executive Vice President	Feb 11 '25	Sale	171.18	326	55,805	16,107	Feb 11 05:15 PM
Lagano Roxanne	Officer	Feb 11 '25	Proposed Sale	171.18	326	55,805		Feb 11 04:33 PM
Polzer Robert J	Executive Vice President	Nov 25 '24	Option Exercise	161.63	3,477	561,985	6,726	Nov 26 04:27 PM
Polzer Robert J	Executive Vice President	Nov 25 '24	Sale	177.46	3,477	617,028	3,249	Nov 26 04:27 PM
Polzer Robert J	Officer	Nov 25 '24	Proposed Sale	177.46	3,477	617,029		Nov 25 04:20 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZTS

Zoetis Inc

Upgrade your FINVIZ experience